KIR2DL3 and acute myeloid leukemia: We investigate the expression of KIR2DL family members in patients with AML and the associated relationship with disease prognosis and immune infiltration based on analysis of data from The Cancer Genome Atlas (TCGA) and Genotype‐Tissue Expression (GTEx) databases and analysis of BM samples.